{"database": "press", "table": "releases", "rows": [["https://deluzio.house.gov/media/press-releases/deluzio-announces-275000-cerebral-aneurysm-testing-work-western-pa-bioscience", "Deluzio Announces $275,000 for Cerebral Aneurysm Testing Work at Western PA Bioscience Company", "2023-11-21", "2023", "2023-11", "Democrat", "House", "PA", "Christopher R. Deluzio", "D000530", "deluzio.house.gov", "deluzio", "https://deluzio.house.gov/media/press-releases", "scraper", "CARNEGIE, PA \u2014 Today, Congressman Chris Deluzio (PA-17) announced a $275,000 grant for Mt. Lebanon-based company Astria Biosciences, Inc. from the National Science Foundation to develop a blood test to detect cerebral aneurysms.\n\n\u201cMany families in Western Pennsylvania will mark Thanksgiving this week without a loved one at the table because far too many underlying health issues go undetected until it\u2019s too late,\u201d said Congressman Chris Deluzio. \u201cEarly detection is key to saving lives and preventing the worst outcomes. I\u2019m proud to announce this grant funding for the work of Pennsylvania\u2019s 17th Congressional District\u2019s own Astria Biosciences, Inc. to make it both cheaper and easier to conduct screenings and testing for cerebral aneurysms.\u201d\n\nSpecifically, this award will fund the project titled \u201cSPIR Phase 1: A Blood Test to Detect Cerebral Aneurysms\u201d and will support Astria Biosciences\u2019 mission to transform diagnosis and treatment for neurological and vascular diseases.\n\nAlmost 30,000 Americans suffer a cerebral aneurysm each year, according to the National Science Foundation. With a 50% mortality rate, cerebral aneurysms can be silent killers, often going undetected. Currently, diagnostics and screenings for these aneurysms often require expensive equipment. New technology and innovative approach to blood testing could provide a new and accessible means to detect and diagnose the underlying causes of brain aneurysms. Astria Bioscience\u2019s research could make it both easier and cheaper to perform these diagnostic tests routinely, increase aneurysm detection, and hopefully save lives.", 1, "2026-03-30T01:40:41Z", "2026-04-08T01:01:09Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://deluzio.house.gov/media/press-releases/deluzio-announces-275000-cerebral-aneurysm-testing-work-western-pa-bioscience"], "units": {}, "query_ms": 1.5766071155667305, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}